Astria Therapeutics, Inc. (ATXS)
NASDAQ: ATXS · Real-Time Price · USD
12.93
-0.19 (-1.45%)
Dec 5, 2025, 4:00 PM EST - Market closed
Astria Therapeutics Market Cap
Astria Therapeutics has a market cap or net worth of $738.11 million as of December 8, 2025. Its market cap has increased by 34.15% in one year.
Market Cap
738.11M
Enterprise Value
514.84M
1-Year Change
34.15%
Ranking
Category
Stock Price
$12.93
Market Cap Chart
Since June 25, 2015, Astria Therapeutics's market cap has increased from $180.00M to $738.11M, an increase of 310.06%. That is a compound annual growth rate of 14.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 738.10M | 46.30% |
| Dec 31, 2024 | 504.50M | 80.95% |
| Dec 29, 2023 | 278.80M | 11.30% |
| Dec 30, 2022 | 250.50M | 257.35% |
| Dec 31, 2021 | 70.10M | 63.02% |
| Dec 31, 2020 | 43.00M | -38.31% |
| Dec 31, 2019 | 69.70M | 124.84% |
| Dec 31, 2018 | 31.00M | -9.88% |
| Dec 29, 2017 | 34.40M | -48.89% |
| Dec 30, 2016 | 67.30M | -44.52% |
| Dec 31, 2015 | 121.30M | -32.61% |
| Jun 25, 2015 | 180.00M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |